Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and F...

Read More

BIIB Performance At-A-Glance

RISK EFFICIENCY

0.87

Biogen Inc's risk efficiency is 0.87, which is OK. By comparison, the S&P500 is -0.39.

Increasing quickly  over the past 4 weeks.

DSCORE

3.14%

Biogen Inc's dScore is 3.14% , which is more volatile than the S&P500 (2.79%).

GROWTH

28.82%

Biogen Inc has grown by 28.82% over the past year.  By comparison, the S&P500 has lost -7.38%.

Portfolios with Biogen Inc